Tamizaje nacional unificado de hipotiroidismo congénito en el Perú: Un programa inexistente

Translated title of the contribution: National congenital hypothyroidism screening in Peru: A broken program

Lina Huerta-Sáenz, Carlos Del Águila, Oscar Espinoza, Juan Falen-Boggio, Naim Mitre

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Congenital hypothyroidism (CH) is the most important cause of preventable mental retardation. The prevalence of CH varies by geographic region, race and ethnicity. In the countries of the Northern hemisphere, the prevalence has been reported as 1:4,000 live newborns. The prevalence is remarkably different among the countries of Latin America not only because of their different races and ethnicities but also because of the heterogeneous social-economic development. The prevalence of CH in 1984 in Peru was reported as 1:1250. In 2007, the reported incidence by the Instituto Nacional Materno Perinatal was 1:1638. A recent retrospective study performed by the Instituto Nacional de Salud del Niño in Lima, Peru described the average age of diagnosis of CH as 5,9 months +/- 5,28. This late age of CH diagnosis certainly suggests the poor efficiency of the current neonatal CH screening programs in Peru. Every Peruvian infant deserves a timely newborn screening and treatment for CH. The Peruvian government is responsible for ensuring this mandatory goal is achieved promptly.

Original languageSpanish
Pages (from-to)579-585
Number of pages7
JournalRevista Peruana de Medicina Experimental y Salud Publica
Volume32
Issue number3
StatePublished - Jul 1 2015

Fingerprint

Congenital Hypothyroidism
Peru
Newborn Infant
Economic Development
Latin America
Intellectual Disability
Retrospective Studies
Incidence

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health

Cite this

Huerta-Sáenz, Lina ; Águila, Carlos Del ; Espinoza, Oscar ; Falen-Boggio, Juan ; Mitre, Naim. / Tamizaje nacional unificado de hipotiroidismo congénito en el Perú : Un programa inexistente. In: Revista Peruana de Medicina Experimental y Salud Publica. 2015 ; Vol. 32, No. 3. pp. 579-585.
@article{c91b79c6a6244bb587ef64c1e1b7eceb,
title = "Tamizaje nacional unificado de hipotiroidismo cong{\'e}nito en el Per{\'u}: Un programa inexistente",
abstract = "Congenital hypothyroidism (CH) is the most important cause of preventable mental retardation. The prevalence of CH varies by geographic region, race and ethnicity. In the countries of the Northern hemisphere, the prevalence has been reported as 1:4,000 live newborns. The prevalence is remarkably different among the countries of Latin America not only because of their different races and ethnicities but also because of the heterogeneous social-economic development. The prevalence of CH in 1984 in Peru was reported as 1:1250. In 2007, the reported incidence by the Instituto Nacional Materno Perinatal was 1:1638. A recent retrospective study performed by the Instituto Nacional de Salud del Ni{\~n}o in Lima, Peru described the average age of diagnosis of CH as 5,9 months +/- 5,28. This late age of CH diagnosis certainly suggests the poor efficiency of the current neonatal CH screening programs in Peru. Every Peruvian infant deserves a timely newborn screening and treatment for CH. The Peruvian government is responsible for ensuring this mandatory goal is achieved promptly.",
author = "Lina Huerta-S{\'a}enz and {\'A}guila, {Carlos Del} and Oscar Espinoza and Juan Falen-Boggio and Naim Mitre",
year = "2015",
month = "7",
day = "1",
language = "Spanish",
volume = "32",
pages = "579--585",
journal = "Revista Peruana de Medicina de Experimental y Salud Publica",
issn = "1726-4634",
publisher = "Instituto Nacional de Salud",
number = "3",

}

Tamizaje nacional unificado de hipotiroidismo congénito en el Perú : Un programa inexistente. / Huerta-Sáenz, Lina; Águila, Carlos Del; Espinoza, Oscar; Falen-Boggio, Juan; Mitre, Naim.

In: Revista Peruana de Medicina Experimental y Salud Publica, Vol. 32, No. 3, 01.07.2015, p. 579-585.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Tamizaje nacional unificado de hipotiroidismo congénito en el Perú

T2 - Un programa inexistente

AU - Huerta-Sáenz, Lina

AU - Águila, Carlos Del

AU - Espinoza, Oscar

AU - Falen-Boggio, Juan

AU - Mitre, Naim

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Congenital hypothyroidism (CH) is the most important cause of preventable mental retardation. The prevalence of CH varies by geographic region, race and ethnicity. In the countries of the Northern hemisphere, the prevalence has been reported as 1:4,000 live newborns. The prevalence is remarkably different among the countries of Latin America not only because of their different races and ethnicities but also because of the heterogeneous social-economic development. The prevalence of CH in 1984 in Peru was reported as 1:1250. In 2007, the reported incidence by the Instituto Nacional Materno Perinatal was 1:1638. A recent retrospective study performed by the Instituto Nacional de Salud del Niño in Lima, Peru described the average age of diagnosis of CH as 5,9 months +/- 5,28. This late age of CH diagnosis certainly suggests the poor efficiency of the current neonatal CH screening programs in Peru. Every Peruvian infant deserves a timely newborn screening and treatment for CH. The Peruvian government is responsible for ensuring this mandatory goal is achieved promptly.

AB - Congenital hypothyroidism (CH) is the most important cause of preventable mental retardation. The prevalence of CH varies by geographic region, race and ethnicity. In the countries of the Northern hemisphere, the prevalence has been reported as 1:4,000 live newborns. The prevalence is remarkably different among the countries of Latin America not only because of their different races and ethnicities but also because of the heterogeneous social-economic development. The prevalence of CH in 1984 in Peru was reported as 1:1250. In 2007, the reported incidence by the Instituto Nacional Materno Perinatal was 1:1638. A recent retrospective study performed by the Instituto Nacional de Salud del Niño in Lima, Peru described the average age of diagnosis of CH as 5,9 months +/- 5,28. This late age of CH diagnosis certainly suggests the poor efficiency of the current neonatal CH screening programs in Peru. Every Peruvian infant deserves a timely newborn screening and treatment for CH. The Peruvian government is responsible for ensuring this mandatory goal is achieved promptly.

UR - http://www.scopus.com/inward/record.url?scp=84949988947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949988947&partnerID=8YFLogxK

M3 - Article

C2 - 26580943

AN - SCOPUS:84949988947

VL - 32

SP - 579

EP - 585

JO - Revista Peruana de Medicina de Experimental y Salud Publica

JF - Revista Peruana de Medicina de Experimental y Salud Publica

SN - 1726-4634

IS - 3

ER -